Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Fidelity

Fidelity Advisor Health Care Fund Class A (FACDX)

Ticker FACDX · · Holdings as of Jul 31, 2026

Expense ratio
0.96%$96/yr per $10k
5-yr return
+2.3%annualized
1-yr return
+7.7%as of Sep 2026
Net assets
$3.1Ball share classes
Holdings
154

Bottom line

Is FACDX a good fund? The bottom line

FACDX is the Class A share class of Fidelity Advisor Health Care Fund, an actively managed health care sector mutual fund from Fidelity.

It charges 0.96% — about $96 a year on every $10,000 invested, more expensive than 51% of health care sector funds we track.

It returned +7.7% over one year, +2.3% a year over five years, +7.6% a year over ten (as of Sep 30, 2026, per its prospectus).

With $3.1 billion in net assets and 154 holdings, its largest position is ELI LILLY and CO (7.7%) and the top 10 make up 41.1% of the portfolio.

What to watch

  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What FACDX invests in

Fidelity Advisor Health Care Fund seeks capital appreciation.

Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's…

From the fund's prospectus (filed Sep 24, 2026).

FACDX performance

Fund calendar-year total returns, 2015–2025 2015: +5.9%; 2016: −10.3%; 2017: +24.1%; 2018: +7.3%; 2019: +27.9%; 2020: +21.1%; 2021: +11.2%; 2022: −13.1%; 2023: +3.8%; 2024: +3.9%; 2025: +14.2% +6% 2015 −10% 2016 +24% 2017 +7% 2018 +28% 2019 +21% 2020 +11% 2021 −13% 2022 +4% 2023 +4% 2024 +14% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FACDX+7.7%+2.3%+7.6%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Sep 30, 2026

Full FACDX performance history →

What FACDX costs

On a $10,000 investment, FACDX's 0.96% expense ratio costs about $96 a year. The prospectus estimates $1,685 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full FACDX fee table →

FACDX top 10 holdings

#Holding% of fund
1ELI LILLY and CO7.66%
2Danaher Corp6.75%
3Thermo Fisher Scientific Inc6.31%
4Unitedhealth Group Inc4.17%
5JOHNSON and JOHNSON3.78%
6Abbvie Inc3.62%
7Fidelity Revere Street Trust2.54%
8Argenx Se2.09%
9MERCK and CO INC2.09%
10West Pharmaceutical Svcs Inc2.06%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 41.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to FACDX

More funds like FACDX →

FACDX FAQ

What is the expense ratio of FACDX?
FACDX's expense ratio is 0.96%, which works out to about $96 a year for every $10,000 invested. The prospectus estimates total costs of $1,685 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FACDX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does FACDX hold?
FACDX's largest holdings are ELI LILLY and CO (7.7%), Danaher Corp (6.8%), Thermo Fisher Scientific Inc (6.3%), Unitedhealth Group Inc (4.2%), JOHNSON and JOHNSON (3.8%). It holds 154 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FACDX's 5-year return?
FACDX returned +2.3% a year over the five years ending Sep 30, 2026, and +7.6% a year over ten years. Past performance does not guarantee future results.
Who manages FACDX?
FACDX is offered by Fidelity through Fidelity Advisor Series Vii.